在化疗后恢复卵巢功能的标志物AMH:IPD元分析和系统审查

Charissa van Zwol-Janssens1, Mandy van M Rosmalen2, Joop S E Laven1

  • 1Division Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Erasmus MC, University Medical Center Rotterdam, the Netherlands.

Cancer treatment reviews
|December 25, 2025
PubMed
概括

化疗前的抗穆勒尔激素 (AMH) 水平预测乳腺癌患者的卵巢功能恢复. 然而,高测定变异性使得无法确定优化内分泌治疗的可靠切断点.